Project Grant R01NS137082
Award Date
12/1/24
Completion Date
11/30/29
Dollars Obligated
$605K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94121, USA
Similar Awards
This Project Grant award, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to investigate a novel pharmacological approach to mitigate neurovascular complications associated with type 2 diabetes in stroke patients. The $459,111 award to the University of Tennessee Health Science Center will fund research exploring the beneficial effects and mechanisms of...
This federal Project Grant award for $853,135 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant will fund research at Dignity Health's St. Joseph's Hospital and Medical Center in Phoenix, AZ to study the role of the complement C3A receptor in exacerbating brain injury and functional impairment following ischemic stroke. The research aims to...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate the role of the CCL2/CCR2 signaling pathway in modulating HIV-associated ischemic stroke severity and recovery. The $422,125 award, effective from September 18, 2024 to August 31, 2026, will be conducted by the University of Miami. The research aims to...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research program (CFDA 93.866), will fund research to investigate the role of neuronal insulin signaling (NIS) and its potential as a biomarker for cognitive impairment in patients with diabetes mellitus (DM). The $350,881 award to the Hennepin Healthcare Research Institute (HHRI) will leverage existing data from the ACCORD-MIND study to analyze NIS-related exosomes in plasma samples and assess their association...
This $624,583 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research at the University of Washington to identify potential therapeutic targets for preventing ischemic stroke. The project will leverage existing plasma samples, genomic data, and electronic medical records from the Heart and Vascular Health Study to evaluate...
This Project Grant award of $192,500 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to define the contribution of endothelial cell sphingolipid metabolism to outcomes of acute ischemic stroke in mice. The award, effective December 1, 2024, will enable the University of Utah to leverage innovative murine models and novel ceramide biosynthesis...
This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $1,023,404 to the University of South Carolina to study the role of cerebrovascular O-GlcNAcylation in predisposing diabetics to stroke, worsening post-stroke neurovascular injury, and impairing functional recovery. The research aims to determine if deficiency of the O-GlcNAc transferase (OGT) enzyme protects against pre-stroke parenchymal arteriole dysfunction...
This Project Grant award of $1,262,930.00, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to examine the influence of cerebral small vessel disease (CSVD) on the net clinical benefit of anticoagulation therapy in intracerebral hemorrhage (ICH) survivors with atrial fibrillation (AF). The key products and services to be delivered include:...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $541,109 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the University of Washington. The 5-year grant, beginning January 1, 2025, will fund research to quantify myelin loss and recovery in ischemic stroke patients using a novel magnetic resonance imaging (MRI) technique called single-point macromolecular proton fraction (MPF) mapping. The...
This federal Project Grant award of $221,120.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to improve neural progenitor (NP) survival and migration for the treatment of neurodegenerative diseases and brain injuries. The project investigates the potential of adult central nervous system (CNS) endothelial cells to express developmental...